Dr. Simon J. Ittig
Chief Executive Officer
Simon completed a PhD on microbial pathogenesis at the University of Basel in the framework of the Werner Siemens Excellence fellowships. He started working on the T3 Pharma technology during his postdoctoral studies at the Biozentrum. For these achievements he received the Novartis and University of Basel Excellence Scholarship in 2014 and a research prize from the Huggenberger-Bischoff foundation for cancer research in the same year.
Dr. Christoph A. Kasper
Chief Scientific Officer
Christoph holds a PhD in cell biology from the University of Basel, which he performed in the framework of the Werner Siemens Excellence fellowships. He acquired profound knowledge in host-microbe interactions and inflammation signaling. Christoph has hands-on experience in high-throughput screening and is skilled in automated image analysis.
Dr. Claire Barton
Chief Medical Officer
Claire is a medical oncologist/pharmaceutical physician specializing in the clinical development of products for oncology indications. Claire has experience in the assessment of in-licensing opportunities and in all aspects of the planning, running, reporting, and publication of international clinical trials (phase I- IV) in diverse areas of oncology. She served the pharmaceutical industry in positions at GlaxoWellcome, Lilly, Roche, and a range of smaller companies and academic groups.